2007
Identifying injection drug users at risk of nonfatal overdose.
Coffin P, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S. Identifying injection drug users at risk of nonfatal overdose. Academic Emergency Medicine 2007, 14: 616-23. PMID: 17554010, DOI: 10.1197/j.aem.2007.04.005.Peer-Reviewed Original ResearchConceptsDrug usersHabitual drug usersNonfatal overdoseAggressive prevention effortsAgonist maintenance treatmentSerious withdrawal symptomsInjection drug usersFurther longitudinal studiesIndividual-level risk factorsTake-home naloxoneOverdose prevention interventionsFuture overdosesMaintenance treatmentWithdrawal symptomsRisk factorsDrug overdoseRecent overdoseEmergency physiciansOverdose riskPrevention interventionsHigh riskOverdoseMedical careYounger ageU.S. adults
2001
Injecting misuse of buprenorphine among French drug users
Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti J. Injecting misuse of buprenorphine among French drug users. Addiction 2001, 96: 267-272. PMID: 11182872, DOI: 10.1046/j.1360-0443.2001.96226710.x.Peer-Reviewed Original ResearchConceptsDrug maintenance treatmentSample of IDUsNeedle exchange programsDrug usersMisuse of buprenorphineCross-sectional surveySelf-administered questionnaireAmbulatory prescriptionsMaintenance treatmentAmbulatory careCommunity pharmaciesBuprenorphineSterile syringesSubstantial riskIDUsLatter groupIllicit usePolydrug usersHIVExchange programsMonthsRisky behaviorsPrescriptionPharmacyMisuse
2000
Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART
Carrieri M, Vlahov D, Dellamonica P, Gallais H, Lepeu G, Spire B, Obadia Y, Group T. Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. Drug And Alcohol Dependence 2000, 60: 51-54. PMID: 10821989, DOI: 10.1016/s0376-8716(00)80007-1.Peer-Reviewed Original ResearchConceptsEfficacy of HAARTDrug usersBuprenorphine substitution treatmentViral load trendsActive antiretroviral therapyFrench cohort studyHIV viral loadUse of buprenorphineInjection drug usersVirologic responseAntiretroviral therapyCohort studyBuprenorphine treatmentTreatment initiationViral loadMaintenance treatmentPotential confoundersHAARTSubstitution treatmentBuprenorphineHIVIndividual treatmentPatientsTreatmentLinear regression models
1994
Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users
Schütz C, Rapiti E, Vlahov D, Anthony J. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug And Alcohol Dependence 1994, 36: 129-138. PMID: 7851280, DOI: 10.1016/0376-8716(94)90095-7.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAmphetamineBaltimoreCocaineCross-Sectional StudiesFemaleFollow-Up StudiesHeroin DependenceHIV InfectionsHumansMaleMethadoneMiddle AgedOpioid-Related DisordersPatient Acceptance of Health CarePatient AdmissionProspective StudiesRisk FactorsSocial EnvironmentSubstance Abuse, IntravenousSubstance-Related DisordersUrban PopulationConceptsMethadone maintenance treatmentMethadone maintenance programDrug usersIndependent predictorsMaintenance treatmentMultiple logistic regression analysisLogistic regression analysisProspective study designTime of recruitmentActive drug usersCross-sectional investigationIDU participantsMethadone maintenanceDrug overdoseNext followDetoxification programCommunity outreach effortsTreatment settingsPrior treatmentDrug useDetoxification treatmentStudy designUntreated drug usersTreatmentRegression analysis